The clinicopathological characteristics received from the pathology department for our sample of BC patients indicated that 15.8% of the patients (144/908) were of the TNBC subtype, with 29 instances being positive for BRCA1 methylation. This evidence concerns the gene BRCA1 and breast cancer.